Contact us for free information or to start a free case review.
The U.S. Food and Drug Administration ordered the makers of Procrit and two other anemia drugs, Epogen and Aranesp, to add a bold black box—the strongest level of warning—to the drugs’ labeling in March 2007. The regulatory action was prompted by safety concerns raised by a study published in the New England Journal of Medicine linking the extremely popular drugs to heart attack, stroke, and other severe side effects. Despite the updated Procrit warning, the drugs continue to be widely used by anemia patients across the country.
Individuals who have been harmed by Procrit may be able to hold Johnson & Johnson, the drug’s maker, responsible for their financial and emotional losses. For a FREE consultation with an experienced Procrit lawyer near you, please contact us today.
Is Procrit Dangerous?
According to the FDA, Procrit can be especially dangerous to patients who are being treated with higher than recommended doses. The black box Procrit warning specifically cites an increased risk of cardiovascular events such as blood clots, heart attack, and stroke in certain kidney patients. In some cases, these events result in death. The new warning also highlights the risk of rapid tumor growth in patients with cancer of the head or neck.
In light of these and other dangers, the FDA said the benefits of Procrit may not outweigh the risks. Recently, agency officials prepared a report in which it said no evidence suggests that Procrit actually improves the quality of life or extends the lifespan of patients being treated with the drug. In fact, when administered in high doses, the drug can shorten a patient’s life span.
Just two months after the FDA announced the Procrit warning, the New York Times published an article stating that dialysis patients in the U.S. receive twice as much Procrit than kidney patients in Europe. Nearly 50 percent of all American dialysis patients are receiving doses higher than deemed safe by the FDA, the article stated.
What Are My Legal Rights?
Even though a Procrit warning now alerts users to the serious dangers of the drug, it comes to late for many who have already taken it and suffered injury as a result. If you or a loved one has suffered an adverse Procrit side effect, you may be entitled to compensation for your medical bills, mental anguish, and other losses.
Contact us today to arrange a complimentary consultation with an experienced attorney near you who can help you understand your legal rights and ensure they are fully protected.
A Food and Drug Administration advisory panel is recommending restrictions on the use of anemia drugs for cancer patients.
The panel recommendation comes in response to growing safety concerns over the risks associated with the anemia drugs Ar...
Anemia drugs known as erythropoiesis-stimulating agents (ESAs) may speed up cancer growth and lead to earlier death in some patients, the Food and Drug Administration announced today citing two new studies.
November Warning
...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.